Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02118805 · ClinicalTrials.gov registry record

Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders

A clinical trial of Stroke and Parkinson's Disease, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
100
Enrollment target
1
Study location

NCT02118805 is a study of Stroke and Parkinson's Disease that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 100 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02118805, a study of Stroke and Parkinson's Disease, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

This study is evaluating the use of two painless, non-invasive technologies in the assessment of muscle health over time in both healthy volunteers and patients who have diseases that affect the nervous system.

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2013-10
Est. Completion 2021-12-31

What the Registry Record Tells You About NCT02118805

The ClinicalTrials.gov registry entry for NCT02118805 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Stroke appearing as the primary indexed condition, and to 0 interventions.

NCT02118805 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02118805 about?

NCT02118805 is a clinical study titled "Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders". This study is evaluating the use of two painless, non-invasive technologies in the assessment of muscle health over time in both healthy volunteers and patients who have diseases that affect the nervous system.

What is the current status of trial NCT02118805?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2013-10. Estimated completion is 2021-12-31.

What conditions does trial NCT02118805 study?

This clinical trial studies the following conditions: Stroke, Parkinson's Disease, Myasthenia Gravis, Amyotrophic Lateral Sclerosis (ALS), Myopathies.

Who is sponsoring clinical trial NCT02118805?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02118805 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.